QQ客服 官方微博 反馈留言

	Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma
	Wang, Xin; Guo, Gaochao; Guan, Hui; Yu, Yang; Lu, Jie; Yu, Jinming
刊名	JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
	2019
卷号	38
关键词	Glioblastoma multiforme Nivolumab Tumour infiltrating lymphocytes Tumour mutation load Temozolomide
DOI	10.1186/s13046-019-1085-3
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4547909
专题	山东大学
作者单位	1.Wuhan Univ, Dept Oncol, Renmin Hosp, Wuhan 430060, Hubei, Peoples R China. 2.Shandong Acad Med Sci, Sh
推荐引用方式 GB/T 7714	Wang, Xin,Guo, Gaochao,Guan, Hui,et al. Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma[J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH,2019,38.
APA	Wang, Xin,Guo, Gaochao,Guan, Hui,Yu, Yang,Lu, Jie,&Yu, Jinming.(2019).Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma.JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH,38.
MLA	Wang, Xin,et al."Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma".JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH 38(2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。